Opdivo, Twitter, 7/27/2019 4:32:16 AM, 205202


FAQ | Problem?

Opdivo_2019-07-26_15-10-11.xlsx
Opdivo_2019-07-26_15-10-11.xlsx
From:
NodeXLExcelAutomator
Uploaded on:
July 27, 2019
Short Description:
Opdivo via NodeXL http://bit.ly/2ydofSL
@bmsnews
@lucidhealthcon
@galeno1999
@marybolanos
@tusaludhispana
@efrainalvaradoa
@sanojaomar
@adamfeuerstein
@fundacionbadan
@gambiste1

Top hashtags:
#opdivo
#nivolumab
#zoladex
#avastin
#rituximab
#nexavar
#caracas
#pharma

Description:
Description
The graph represents a network of 1,364 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Friday, 26 July 2019 at 22:10 UTC.

The requested start date was Thursday, 25 July 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.

The tweets in the network were tweeted over the 84-day, 23-hour, 13-minute period from Wednesday, 01 May 2019 at 00:44 UTC to Wednesday, 24 July 2019 at 23:57 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 1364
Unique Edges : 1426
Edges With Duplicates : 930
Total Edges : 2356
Number of Edge Types : 3
Mentions : 1444
Tweet : 719
Replies to : 193
Self-Loops : 719
Reciprocated Vertex Pair Ratio : 0.0103503184713376
Reciprocated Edge Ratio : 0.020488573680063
Connected Components : 367
Single-Vertex Connected Components : 272
Maximum Vertices in a Connected Component : 434
Maximum Edges in a Connected Component : 1103
Maximum Geodesic Distance (Diameter) : 19
Average Geodesic Distance : 6.948028
Graph Density : 0.000682576600262918
Modularity : 0.577384
NodeXL Version : 1.0.1.417

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[28] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[13] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[10] http://benzaiten.dyndns.org/roller/ugya/entry/honjo-tasuku-opdivo
[9] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[8] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[7] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[7] https://www.consalud.es/industria/bristol-myers-squibb-anuncia-resultados-de-nivolumab-opdivo-en-pacientes-con-cpnm_66517_102_amp.html

Top URLs in Tweet in G1:
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[6] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[5] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews&utm_source=dlvr.it&utm_medium=twitter
[5] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[5] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[5] https://lungcancersymptomsx.com/a-hope-for-mesothelioma-patients-with-new-lung-cancer-drug-opdivo.html
[4] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8
[4] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter

Top URLs in Tweet in G2:
[1] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter

Top URLs in Tweet in G3:
[3] https://endpts.com/bristol-myers-does-it-again-disappointing-investors-with-another-failed-opdivo-phiii-as-227-flops/
[2] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[2] https://www.youtube.com/watch?v=WDDxSO_7DxU

[2] https://www.fiercebiotech.com/biotech/complete-response-rate-nektar-melanoma-trial-hits-34
[2] https://seekingalpha.com/news/3473157
[2] https://twitter.com/bio_clouseau/status/1143111436241162241
[1] https://www.businesswire.com/news/home/20190517005520/en
[1] http://ir.beigene.com/news-releases/news-release-details/beigene-regains-full-global-rights-its-investigational-anti-pd-1
[1] https://www.fiercebiotech.com/biotech/neon-therapeutics-neoantigen-vaccine-boosts-opdivo-response-3-cancers
[1] https://twitter.com/NewsFromBW/status/1126443362767081472

Top URLs in Tweet in G6:
[1] https://www.instagram.com/p/Bzw9zainZet5RPei55oe3q-Oms2GkPxZ0fBmCQ0/?igshid=kgblw7wy62dl

Top URLs in Tweet in G7:
[4] https://news.bms.com/press-release/asco19/bristol-myers-squibb-announces-first-presentation-results-opdivo-nivolumab-plus?linkId=68472488
[3] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/
[3] https://finance.yahoo.com/news/bristol-myers-bmy-presents-multiple-130301742.html
[2] https://media.bayer.com/baynews/baynews.nsf/id/Bayer-Bristol-Myers-Squibb-Ono-Pharmaceutical-enter-a-clinical-collaboration-agreement-investigate
[2] http://www.pharmatimes.com/news/bms_opdivo_disappoints_in_late-stage_trial_1292613
[2] https://pharmaphorum.com/news/bms-has-another-opdivo-setback-after-liver-cancer-trial-failure/?utm_source=pharmaphorum+Daily+Newsletter&utm_campaign=e64cb98ac2-EMAIL_CAMPAIGN_2019_06_25_11_55&utm_medium=email&utm_term=0_a54496134b-e64cb98ac2-438901029
[2] http://www.pharmatimes.com/news/imfinzi,_opdivo_among_latest_smc_decisions_1290505
[2] https://medcitynews.com/2019/06/nektars-bempeg-shows-encouraging-phase-ii-data-in-first-line-melanoma-with-bms-opdivo/
[1] https://www.consalud.es/ecsalud/internacional/bristol-myers-squibb-presentara-nuevos-datos-de-su-pipeline-en-oncologia-en-20-tipos-de-tumores_64385_102.html

Top URLs in Tweet in G8:
[15] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://bit.ly/2x70MSX
[1] https://twitter.com/InfoCancerFoie/status/1143217317888823296
[1] https://clinicaltrials.gov/ct2/show/NCT02576509?term=nivolumab+checkmate&cond=Hepatocellular+Carcinoma&rank=3

Top URLs in Tweet in G10:
[5] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[2] http://firstwordpharma.com/node/1654976?tsid=28®ion_id=6
[2] https://www.fiercepharma.com/pharma/bristol-myers-squibb-bayer-team-up-opdivo-stivarga-combo-colorectal-cancer
[1] https://www.firstwordpharma.com/node/1639819
[1] https://www.firstwordpharma.com/node/1649087
[1] https://www.fiercepharma.com/pharma/bristol-myers-opdivo-fails-to-beat-nexavar-earlier-use-liver-cancer
[1] https://www.fiercepharma.com/pharma/bristol-myers-opdivo-fails-brain-tumor-test-again-time-new-patients
[1] https://www.fiercepharma.com/pharma/merck-s-keytruda-gives-opdivo-some-company-small-cell-lung-cancer-nod

Top Domains
Top Domains in Tweet in Entire Graph:
[50] fiercepharma.com
[47] bms.com
[39] twitter.com
[31] dlvr.it
[29] reuters.com
[22] medcitynews.com
[18] co.jp
[16] pharmatimes.com
[15] blogspot.com
[13] endpts.com

Top Domains in Tweet in G1:
[26] reuters.com
[23] fiercepharma.com
[18] twitter.com
[17] dlvr.it
[15] medcitynews.com
[12] blogspot.com
[11] com.br
[10] co.jp
[10] jiho.jp
[9] 1stoncology.com

Top Domains in Tweet in G2:
[1] buzzfeed.com

Top Domains in Tweet in G3:
[11] twitter.com
[6] endpts.com
[5] dlvr.it
[4] fiercebiotech.com
[4] bms.com
[3] seekingalpha.com
[2] youtube.com
[1] businesswire.com
[1] beigene.com
[1] aacrjournals.org

Top Domains in Tweet in G6:
[1] instagram.com

Top Domains in Tweet in G7:
[8] bms.com
[8] pharmaphorum.com
[6] pharmatimes.com
[3] pharmaceutical-technology.com
[3] yahoo.com
[3] medcitynews.com
[2] consalud.es
[2] acobur.es
[2] bayer.com
[2] pharmashots.com

Top Domains in Tweet in G8:
[19] bms.com
[3] bit.ly
[1] twitter.com
[1] clinicaltrials.gov

Top Domains in Tweet in G10:
[10] fiercepharma.com
[4] firstwordpharma.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[178] opdivo
[127] nivolumab
[56] zoladex
[47] avastin
[47] rituximab
[38] nexavar
[35] caracas
[28] pharma
[26] sutent
[25] sorafenib



Top Hashtags in Tweet in G1:
[41] opdivo
[13] pharma
[13] nivolumab
[12] januvia
[12] lantus
[12] prevnar13
[12] neulasta
[10] janumet
[10] prevener
[10] peglasta

Top Hashtags in Tweet in G3:
[8] nivolumab
[5] asco19
[3] opdivo
[3] carcinome
[2] sorafenib
[1] keytruda
[1] ici
[1] dcvax
[1] chimiothérapie
[1] cetuximab

Top Hashtags in Tweet in G4:
[76] opdivo
[66] nivolumab
[56] zoladex
[47] rituximab
[37] nexavar
[35] caracas
[33] avastin
[24] capecitabina
[23] docetaxel
[22] xeloda

Top Hashtags in Tweet in G6:
[28] opdivo
[15] valencia
[15] venezuela
[15] quimioterapias
[15] nivolumab
[13] medicamentos
[13] sandostatinlar
[13] avastin
[13] sutent

Top Hashtags in Tweet in G7:
[8] melanoma
[7] hcc
[6] media
[5] asco19
[5] opdivo
[5] pharma
[4] nivolumab
[4] pharmanews
[3] cancer
[3] trial

Top Hashtags in Tweet in G8:
[8] hcc
[5] hepatocellularcarcinoma
[5] livercancer
[5] treatment
[3] pressrelease
[2] nivolumab
[2] sorafenib
[1] media

Top Hashtags in Tweet in G10:
[2] pharma

Top Words
Top Words in Tweet in Entire Graph:
[780] Words in Sentiment List#1: Positive
[932] Words in Sentiment List#2: Negative
[2] Words in Sentiment List#3: Angry/Violent
[34364] Non-categorized Words
[36076] Total Words
[1170] opdivo
[355] nivolumab
[351] cancer
[321] bristol
[231] trial

Top Words in Tweet in G1:
[385] opdivo
[180] cancer
[170] bristol
[105] myers
[92] fails
[92] trial
[84] nivolumab
[80] brain
[80] phase
[75] study

Top Words in Tweet in G2:
[187] satoruo
[187] がんと免疫については
[187] 以前にバズフィードに解説記事を書いています
[187] 免疫はたしかにがん治療に重要なのですが
[187] それを一般生活にある食品
[187] 食事療法などで
[187] 大きく変えて
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] 記事をご参考に
[66] ã

Top Words in Tweet in G3:
[185] opdivo
[111] bmy
[58] keytruda
[41] 2
[38] trial
[36] cancer
[33] combo
[33] checkmate
[32] line
[31] 1l

Top Words in Tweet in G4:
[76] #opdivo
[66] #nivolumab
[56] #zoladex
[47] #rituximab
[46] serviciopublive
[39] donamed_ve
[39] medcancervzla
[37] buscandomedicin
[37] #nexavar
[36] sebuscasedona

Top Words in Tweet in G5:
[62] bir
[61] 2
[60] barisyarkadas
[60] kutusu
[60] 28
[60] bin
[60] tl'den
[60] satılan
[60] ve
[60] ay

Top Words in Tweet in G6:
[62] ampollas
[58] opdivo
[56] nivolumab
[44] requiere
[44] urgencia
[29] 18
[28] #opdivo
[24] fundacionbadan
[17] 100mg
[16] danibolanos

Top Words in Tweet in G7:
[52] opdivo
[37] bmsnews
[15] phase
[13] nivolumab
[10] trial
[10] cancer
[10] first
[10] patients
[9] bristol
[9] myers

Top Words in Tweet in G8:
[51] sorafenib
[50] nivolumab
[35] survival
[33] improve
[26] trial
[25] results
[25] checkmate
[25] 459
[24] overall
[20] show

Top Words in Tweet in G9:
[3] vprasadmdmph
[3] opdivo
[2] drugs
[2] before
[2] pd
[2] new
[2] bristol

Top Words in Tweet in G10:
[66] opdivo
[61] pd
[57] made
[53] bristol
[52] myers
[50] thenci
[49] nivolumab
[40] 1
[39] squibb
[33] keytruda

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[230] bristol,myers
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[183] opdivo,nivolumab

Top Word Pairs in Tweet in G1:
[105] bristol,myers
[84] opdivo,fails
[74] brain,cancer
[66] opdivo,nivolumab
[59] myers,squibb
[58] late,stage
[54] cancer,trial
[53] stage,brain
[52] bristol,myers'
[51] myers',opdivo

Top Word Pairs in Tweet in G2:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[38] ã,ã
[6] ã,œã

Top Word Pairs in Tweet in G3:
[27] non,squamous
[26] final,nail
[26] nail,coffin
[26] coffin,opdivo
[26] opdivo,indeed
[26] indeed,inferior
[26] inferior,keytruda
[26] keytruda,1l
[26] 1l,non
[26] squamous,nsclc

Top Word Pairs in Tweet in G4:
[49] #opdivo,#nivolumab
[23] #rituximab,#capecitabina
[22] #caracas,#rituximab
[22] #capecitabina,#xeloda
[22] #xeloda,#taxol
[22] #taxol,#nexavar
[22] #nexavar,#zoldonat
[22] #zoldonat,#zoladex
[22] #zoladex,#opdivo
[22] #nivolumab,#docetaxel

Top Word Pairs in Tweet in G5:
[60] 2,kutusu
[60] kutusu,28
[60] 28,bin
[60] bin,tl'den
[60] tl'den,satılan
[60] satılan,ve
[60] ve,ay
[60] ay,kullanılmak
[60] kullanılmak,zorunda
[60] zorunda,opdivo

Top Word Pairs in Tweet in G6:
[53] opdivo,nivolumab
[44] requiere,urgencia
[30] ampollas,opdivo
[29] urgencia,18
[29] 18,ampollas
[16] nivolumab,12
[16] 12,ampollas
[16] ampollas,100mg
[16] 100mg,6
[16] 6,ampollas

Top Word Pairs in Tweet in G7:
[9] bristol,myers
[8] opdivo,nivolumab
[7] myers,squibb
[5] nivolumab,opdivo
[5] clinical,trial
[4] phase,3
[4] announced,dosing
[4] dosing,first
[4] first,patient
[4] patient,phase

Top Word Pairs in Tweet in G8:
[25] checkmate,459
[22] overall,survival
[20] results,checkmate
[20] 459,trial
[20] trial,show
[20] show,nivolumab
[20] nivolumab,improve
[20] improve,overall
[20] survival,compared
[20] compared,sorafenib

Top Word Pairs in Tweet in G10:
[52] bristol,myers
[44] nivolumab,opdivo
[39] pd,1
[39] myers,squibb
[27] made,bristol
[26] pembrolizumab,keytruda
[25] 1,blocking
[21] opdivo,made
[20] made,merck
[19] pd,l1

Top Replied-To
Top Replied-To in Entire Graph:
@thenci
@fundacionbadan
@bmsnews
@buscandomedicin
@julioespinoza4
@bradloncar
@ca601ff0a58d454
@medcancervzla
@claredotexe
@veteranshealth

Top Replied-To in G3:
@bradloncar
@matthewherper
@adamfeuerstein
@dewdiligence
@bursatilbiotech
@rogerb06385286
@howardschlauch
@queencity_leeds
@dodawuk
@chickpea598

Top Replied-To in G4:
@fundacionbadan
@buscandomedicin
@medcancervzla
@quimiov
@julioespinoza4
@freddyflash1
@sebuscasedona
@accionsolidaria
@fncancer
@donamed_ve

Top Replied-To in G5:
@barisyarkadas

Top Replied-To in G6:
@ca601ff0a58d454
@julioespinoza4
@sheigagli
@7domadriana
@santicancerosa
@medicinatogogm1
@maydavila1

Top Replied-To in G7:
@bmsnews
@nektar
@curemelanoma

Top Replied-To in G9:
@rskemp01
@mikejohansenmd
@akapczynski

Top Replied-To in G10:
@thenci
@veteranshealth
@ncicancertrials
@catrionam_d

Top Mentioned
Top Mentioned in Entire Graph:
@satoruo
@barisyarkadas
@serviciopublive
@bmsnews
@donamed_ve
@ayudasosvzla
@medcancervzla
@sebuscasedona
@buscandomedicin
@sosmedicina

Top Mentioned in G1:
@clinicalphase
@cmencke
@judsontelemed
@ray_noble1
@womens_womens
@nailethv
@lmmarknaden
@larvol
@lungcancer_bio

Top Mentioned in G2:
@satoruo

Top Mentioned in G3:
@andybiotech
@johncendpts
@adamfeuerstein
@jacobplieth
@matthewherper
@sxbegle
@bradloncar
@dewdiligence
@fiercebiotech
@endpts

Top Mentioned in G4:
@serviciopublive
@donamed_ve
@medcancervzla
@ayudasosvzla
@sebuscasedona
@buscandomedicin
@sosmedicina
@publserv
@medicinasve
@esedesalud

Top Mentioned in G5:
@barisyarkadas

Top Mentioned in G6:
@fundacionbadan
@danibolanos
@face_uc
@fapuv
@apucoficial
@quimiosalud
@marybolanos
@galeagustavo
@evita4
@galeno1999

Top Mentioned in G7:
@bmsnews
@biotechvisigoth
@bayer
@bayerpharma
@tarisbio
@xbranebiopharma
@medcitynews
@pharmatimes
@curemelanoma
@nektar

Top Mentioned in G8:
@bclc_group
@augustonyc
@aeehliver
@infocancerfoie
@bmsnews
@dufour_jf
@jturnesv
@adiazgonzalezmd

Top Mentioned in G9:
@vprasadmdmph
@venkmurthy
@oncology_bg
@drjohnm
@cmichaelgibson
@onco_cardiology
@drmarthagulati
@purviparwani
@roguerad
@anish_koka

Top Mentioned in G10:
@fwpharma
@fiercepharma
@nci_cssi
@treda10
@thenci
@digitalpharma

Top Tweeters
Top Tweeters in Entire Graph:
@myalliesnews
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@tradnews_
@razzletazzlemag
@marketcurrents
@duinconsueloc
@gogiuk

Top Tweeters in G1:
@myalliesnews
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@razzletazzlemag
@marketcurrents
@gogiuk
@newsfromspi
@crweworld

Top Tweeters in G2:
@hayohater
@suigadou
@kumikokatase
@kinginsunago
@kgn_works
@socio34050
@mifasorahula
@aim54_phoenix
@maetaru2
@alcedo_kawasemi

Top Tweeters in G3:
@bioportfolio
@mr_showkz99
@gambiste1
@cancer_bio
@donnayoungdc
@johnnosta
@jimcramer
@portefeuillefun
@matthewherper
@stockmatusow

Top Tweeters in G4:
@duinconsueloc
@vetehugo
@arquitecty
@pecescd
@hapariciog1108
@serviciopublive
@tamaracoromoto
@onehundredon
@donamed_ve
@chuotorrealba

Top Tweeters in G5:
@barisyarkadas
@no_rumuz
@ezgisutoprak
@nathan61641442
@sebahatturkmen
@kkbirocuk1
@fkoruyucu1
@zehrabozca
@svmaktryldz
@meralyilmazlar

Top Tweeters in G6:
@cristobalvega
@mairaazuje
@fundacionbadan
@pocahontas0205
@antoniojdo
@reinaseq
@anyrmontes28
@flaquinha96
@nrodriguez7
@vanesadepombo

Top Tweeters in G7:
@urotoday
@hernangraffe
@samadovaabditch
@pharmaphorum
@ecsalud_com
@ci4cc
@chocolatierep
@medcitynews
@mimigirlsmom
@iitolifescience

Top Tweeters in G8:
@drjhk
@fpazgomez
@tamarnegie
@hakosemi
@carmenvcello
@sepdigestiva
@rplanasv
@jturnesv
@drjaviercrespo
@birminghamliver

Top Tweeters in G9:
@drmarthagulati
@cmichaelgibson
@roguerad
@vprasadmdmph
@venkmurthy
@onco_cardiology
@cdcgov
@oncology_bg
@anish_koka
@purviparwani

Top Tweeters in G10:
@saintporres
@treda10
@annemarievtw
@fwpharma
@veteranshealth
@fiercepharma
@thenci
@vanprobindia
@digitalpharma
@onkosconsulting


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.